The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in ...

The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have ...

Priority Health, a Michigan-based insurer, announced Wednesday that it has launched two new cancer support solutions for employers in partnership with Color Health and Grail. The insurer serves more ...

For one ICU physician and startup CMO, the more immediate danger isn’t an autonomous system taking over medicine and leaving ...

AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

Tiny Health's Series B round was led by B Capital, with participation from Spero Ventures, The Venture City, Overwater Ventures, Black Opal Ventures, Denver Ventures, Pave Health Ventures, Alumni ...

Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...

When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...

CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

They see the problem first, build the fix, and decide whether it is ever adopted. The market has trained them to hide the one credential that de-risks the deal.